Products for Research Use Only

Benorilate

CAT: 0804-HY-107795-01Size: 5 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-107795-01Size:5 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Benorylate (Salipran) is the esterification product of paracetamol and acetylsalicylic acid. Benorylate has anti-inflammatory, analgesic and antipyretic properties. Benorylate could also inhibit prostaglandin (PG) synthesis[1][2][3][4].
CAS Number
5003-48-5
Product Name Alternative
Salipran
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H332, H335
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Endocrinology
Assay Protocol
https://www.medchemexpress.com/Benorilate.html
Concentration
10mM
Purity
99.85
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(OC1=CC=C(NC(C)=O)C=C1)C2=CC=CC=C2OC(C)=O
Molecular Formula
C17H15NO5
Molecular Weight
313.30
Precautions
H302, H315, H319, H332, H335
References & Citations
[1]Croft DN, et al. Gastric bleeding and benorylate, a new aspirin. Br Med J. 1972 Sep 2;3 (5826) :545-7.|[2]Castell JV, et al. Effects of benorylate and impacina on the metabolism of cultured hepatocytes. Xenobiotica. 1985 Aug-Sep;15 (8-9) :743-9.|[3]Wright V, et al. A review of benorylate - a new antirheumatic drug. Scand J Rheumatol Suppl. 1975;13:5-8.|[4]A. Bennett , et al. Inhibition of Prostaglandin Synthesis by Benorylate. Rheumatology, Volume XII, Issue suppl, 1 January 1973, Pages 101-105.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Launched

Popular Products